Shanghai Junshi Biosciences (SHA:688180, HKG:1877) said Shanghai Tanying Investment Partnership is planning to reduce its shareholding in the company by up to over 20.5 million shares.
Shanghai Tanying Investment Partnership holds 38.9 million China-listed shares in the company, according to a Monday Hong Kong bourse filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.